PLX

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Protalix Biotherapeutics Inc

NYSE MKT | PLX

1.86

USD

$0.00

(

0.00%

)

At Close (As of Oct 17, 2025)

$191.36M

Market Cap

26.67

P/E Ratio

0.09

EPS

$3.10

52 Week High

$1.01

52 Week Low

HEALTHCARE

Sector

PLX Chart

Recent Chart
Price Action

PLX Technicals

Tags:

PLX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $29M
Total Revenue $53M
Cost Of Revenue $24M
Costof Goods And Services Sold $24M
Operating Income $3.9M
Selling General And Administrative $41M
Research And Development $13M
Operating Expenses $25M
Investment Income Net -
Net Interest Income $237K
Interest Income $1.3M
Interest Expense $1.1M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.3M
Income Before Tax $4.2M
Income Tax Expense $1.2M
Interest And Debt Expense -
Net Income From Continuing Operations $2.9M
Comprehensive Income Net Of Tax -
Ebit $5.2M
Ebitda $6.5M
Net Income $2.9M

Revenue & Profitability

Earnings Performance

PLX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $73M
Total Current Assets $60M
Cash And Cash Equivalents At Carrying Value $20M
Cash And Short Term Investments $20M
Inventory $21M
Current Net Receivables $2.9M
Total Non Current Assets $13M
Property Plant Equipment $10M
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $15M
Other Current Assets $1.1M
Other Non Current Assets -
Total Liabilities $30M
Total Current Liabilities $26M
Current Accounts Payable $4.5M
Deferred Revenue -
Current Debt -
Short Term Debt $3M
Total Non Current Liabilities $4.6M
Capital Lease Obligations $5.5M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $5.5M
Other Current Liabilities $15M
Other Non Current Liabilities -
Total Shareholder Equity $43M
Treasury Stock -
Retained Earnings -$378M
Common Stock $76K
Common Stock Shares Outstanding $81M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $8.7M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.3M
Capital Expenditures $1.3M
Change In Receivables -
Change In Inventory -$2.2M
Profit Loss -
Cashflow From Investment $4.2M
Cashflow From Financing -$17M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $3.6M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $2.9M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $29M
Total Revenue $53M
Cost Of Revenue $24M
Costof Goods And Services Sold $24M
Operating Income $3.9M
Selling General And Administrative $41M
Research And Development $13M
Operating Expenses $25M
Investment Income Net -
Net Interest Income $237K
Interest Income $1.3M
Interest Expense $1.1M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.3M
Income Before Tax $4.2M
Income Tax Expense $1.2M
Interest And Debt Expense -
Net Income From Continuing Operations $2.9M
Comprehensive Income Net Of Tax -
Ebit $5.2M
Ebitda $6.5M
Net Income $2.9M

PLX Profile

Protalix Biotherapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Protalix Biotherapeutics Inc. is an innovative biopharmaceutical company based in Karmiel, Israel, that specializes in the development and commercialization of recombinant therapeutic proteins through its unique ProCellEx plant cell-based expression system. Focused on addressing unmet medical needs, Protalix is advancing treatments for various conditions in markets including Israel, Brazil, and Latin America. Its commitment to biotechnology and strategic international expansion positions Protalix as a significant entity within the biotech landscape, promising potential for growth and enhanced patient outcomes globally.

VHAI
-25.00%
$0.00
RANI
+248.26%
$1.64
BYND
+24.15%
$0.64
YYAI
+0.83%
$0.12
YDKG
-40.50%
$0.05
CGBS
-39.47%
$0.03
BITF
-5.11%
$5.01
NVDA
+0.77%
$183.22
INTC
+0.46%
$37.01
RGTI
-3.31%
$46.38
GDXD
+20.23%
$0.72
F
+1.53%
$11.92
PLUG
-2.29%
$3.40
ARTV
+116.96%
$6.01
BURU
+0.85%
$0.34
TSLA
+2.46%
$439.31
DNN
-5.50%
$2.92
BBD
+1.22%
$3.30
IONZ
+7.55%
$3.70
HBAN
+0.84%
$15.50
NIO
-1.17%
$6.75
CAN
-4.19%
$1.60
NVTS
-6.20%
$14.66
HIMS
-15.84%
$49.78
RXRX
-7.86%
$5.86
TLRY
+1.29%
$1.56
AXDX
-61.36%
$0.03
BTG
-6.56%
$5.55
HPE
+2.04%
$22.96
LAES
+4.87%
$6.67
RGTZ
+6.58%
$11.97
ETHD
+2.25%
$4.09
ELBM
+35.36%
$2.22
T
+0.53%
$26.34
BLMZ
-3.85%
$0.18
ACHR
-5.30%
$11.24
AMD
-0.63%
$233.08
CIFR
+0.21%
$18.76
KVUE
+8.36%
$15.29
WTO
-47.99%
$0.07
GNPX
-23.68%
$0.36
LNKS
+30.35%
$0.73
RIG
+0.92%
$3.26
GPUS
-11.96%
$0.32
MARA
-3.42%
$19.57
AAPL
+1.95%
$252.29
BAC
+1.66%
$51.28
JOBY
-2.55%
$15.66
RF
+0.98%
$23.58
SOUN
-8.38%
$19.02
SOFI
-0.22%
$26.54
AMZN
-0.66%
$213.04
QBTS
-5.26%
$38.33
PLTR
+0.01%
$178.15
EPWK
-18.45%
$0.07
ONDS
-7.19%
$7.61
GRAB
-1.22%
$5.64
QUBT
-2.18%
$18.32
ADAP
+2.51%
$0.20
PFE
+1.15%
$24.51
RMBL
+60.50%
$3.21
BMNR
-2.40%
$49.85
SLB
-0.88%
$32.63
ABEV
+0.89%
$2.25
IREN
-1.79%
$60.72
ASST
-7.28%
$0.83
ADD
-25.47%
$0.05
ORCL
-6.92%
$291.31
SNAP
-1.41%
$7.65
CRML
+7.41%
$20.86
DFLI
+2.25%
$1.36
BTBT
-1.08%
$3.65
SRM
+53.27%
$10.30
AAL
-0.25%
$11.86
NEHC
+44.44%
$4.55
NUAI
+44.44%
$4.55
IONQ
-4.04%
$62.94
WULF
+0.50%
$13.93
NAK
-8.48%
$2.04
NOK
+1.05%
$5.74
ATAI
+17.70%
$6.45
RR
-4.05%
$5.44
CLSK
-2.32%
$19.52
GWH
+16.04%
$5.28
SMR
-7.11%
$44.25
APLD
-6.55%
$34.24
CRWV
-3.43%
$136.87
QS
-0.64%
$15.36
GOOGL
+0.73%
$253.30
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
UUUU
-2.90%
$21.06
VALE
-0.09%
$11.10
WLGS
-5.57%
$0.04
FNB
+3.00%
$15.09
BULL
-6.29%
$11.01
AG
-8.51%
$14.02
VIVK
-29.17%
$0.20
LBRT
+28.30%
$15.32
ETWO
0.00%
$3.30
VHAI
-25.00%
$0.00
RANI
+248.26%
$1.64
BYND
+24.15%
$0.64
YYAI
+0.83%
$0.12
YDKG
-40.50%
$0.05
CGBS
-39.47%
$0.03
BITF
-5.11%
$5.01
NVDA
+0.77%
$183.22
INTC
+0.46%
$37.01
RGTI
-3.31%
$46.38
GDXD
+20.23%
$0.72
F
+1.53%
$11.92
PLUG
-2.29%
$3.40
ARTV
+116.96%
$6.01
BURU
+0.85%
$0.34
TSLA
+2.46%
$439.31
DNN
-5.50%
$2.92
BBD
+1.22%
$3.30
IONZ
+7.55%
$3.70
HBAN
+0.84%
$15.50
NIO
-1.17%
$6.75
CAN
-4.19%
$1.60
NVTS
-6.20%
$14.66
HIMS
-15.84%
$49.78
RXRX
-7.86%
$5.86
TLRY
+1.29%
$1.56
AXDX
-61.36%
$0.03
BTG
-6.56%
$5.55
HPE
+2.04%
$22.96
LAES
+4.87%
$6.67
RGTZ
+6.58%
$11.97
ETHD
+2.25%
$4.09
ELBM
+35.36%
$2.22
T
+0.53%
$26.34
BLMZ
-3.85%
$0.18
ACHR
-5.30%
$11.24
AMD
-0.63%
$233.08
CIFR
+0.21%
$18.76
KVUE
+8.36%
$15.29
WTO
-47.99%
$0.07
GNPX
-23.68%
$0.36
LNKS
+30.35%
$0.73
RIG
+0.92%
$3.26
GPUS
-11.96%
$0.32
MARA
-3.42%
$19.57
AAPL
+1.95%
$252.29
BAC
+1.66%
$51.28
JOBY
-2.55%
$15.66
RF
+0.98%
$23.58
SOUN
-8.38%
$19.02
SOFI
-0.22%
$26.54
AMZN
-0.66%
$213.04
QBTS
-5.26%
$38.33
PLTR
+0.01%
$178.15
EPWK
-18.45%
$0.07
ONDS
-7.19%
$7.61
GRAB
-1.22%
$5.64
QUBT
-2.18%
$18.32
ADAP
+2.51%
$0.20
PFE
+1.15%
$24.51
RMBL
+60.50%
$3.21
BMNR
-2.40%
$49.85
SLB
-0.88%
$32.63
ABEV
+0.89%
$2.25
IREN
-1.79%
$60.72
ASST
-7.28%
$0.83
ADD
-25.47%
$0.05
ORCL
-6.92%
$291.31
SNAP
-1.41%
$7.65
CRML
+7.41%
$20.86
DFLI
+2.25%
$1.36
BTBT
-1.08%
$3.65
SRM
+53.27%
$10.30
AAL
-0.25%
$11.86
NEHC
+44.44%
$4.55
NUAI
+44.44%
$4.55
IONQ
-4.04%
$62.94
WULF
+0.50%
$13.93
NAK
-8.48%
$2.04
NOK
+1.05%
$5.74
ATAI
+17.70%
$6.45
RR
-4.05%
$5.44
CLSK
-2.32%
$19.52
GWH
+16.04%
$5.28
SMR
-7.11%
$44.25
APLD
-6.55%
$34.24
CRWV
-3.43%
$136.87
QS
-0.64%
$15.36
GOOGL
+0.73%
$253.30
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
UUUU
-2.90%
$21.06
VALE
-0.09%
$11.10
WLGS
-5.57%
$0.04
FNB
+3.00%
$15.09
BULL
-6.29%
$11.01
AG
-8.51%
$14.02
VIVK
-29.17%
$0.20
LBRT
+28.30%
$15.32
ETWO
0.00%
$3.30
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.